Health Catalyst, Inc.
HCAT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $262 | $311 | $441 |
| - Cash | $40 | $51 | $342 | $250 |
| + Debt | $167 | $173 | $402 | $402 |
| Enterprise Value | – | $385 | $371 | $594 |
| Revenue | $76 | $81 | $79 | $80 |
| % Growth | -5.4% | 1.6% | -0.2% | – |
| Gross Profit | $38 | $38 | $36 | $35 |
| % Margin | 49.5% | 47.4% | 45.6% | 43.6% |
| EBITDA | -$4 | -$22 | -$4 | -$2 |
| % Margin | -5.2% | -27.8% | -4.9% | -3.1% |
| Net Income | -$22 | -$41 | -$24 | -$21 |
| % Margin | -29.1% | -50.8% | -29.9% | -26% |
| EPS Diluted | -0.32 | -0.59 | -0.35 | -0.33 |
| % Growth | 45.8% | -68.6% | -6.1% | – |
| Operating Cash Flow | -$0 | -$9 | $0 | -$4 |
| Capital Expenditures | -$5 | $0 | -$1 | -$5 |
| Free Cash Flow | -$5 | -$9 | -$0 | -$8 |